Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caracciolo

Showing results (931-940 of 982) with videos related to

Pageof 99
Sort By:
Parkinsonism & Related Disorders|August 3, 2018
A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's diseaseAldo Quattrone, Maurizio Morelli, Salvatore Nigro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphomaCorrado Tarella, Roberto Passera, Michele Magni, et al.
Scientific Reports|October 29, 2025
Conservation hints for Pinna nobilis from a century-old genetic time capsuleIlenia Azzena, Chiara Locci, Noemi Pascale, et al.
Leukemia|July 8, 2020
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myelomaMarco Rossi, Emanuela Altomare, Cirino Botta, et al.
BMC Genomics|January 11, 2014
Differential transcriptional profile of Corynebacterium pseudotuberculosis in response to abiotic stressesAnne Cybelle Pinto, Pablo Henrique Caracciolo Gomes de Sá, Rommel T J Ramos, et al.
Annals of Botany|October 24, 2024
Expanding the Triangle of U: Comparative analysis of the Hirschfeldia incana genome provides insights into chromosomal evolution, phylogenomics and high photosynthesis-related traitsNam V Hoang, Nora Walden, Ludovico Caracciolo, et al.
Leukemia|November 22, 2017
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cellsC Botta, M Cucè, M R Pitari, et al.
Blood|July 13, 2018
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92Eugenio Morelli, Lavinia Biamonte, Cinzia Federico, et al.
Cells|August 29, 2020
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced PneumonitisPierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, et al.
British Journal of Haematology|July 3, 2026
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experienceAndrea Duminuco, Dario Leotta, Alessandro Allegra, et al.
Pageof 99

Showing results (931-940 of 982) with videos related to

Sort By:
Pageof 99
Parkinsonism & Related Disorders|August 3, 2018
A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's diseaseAldo Quattrone, Maurizio Morelli, Salvatore Nigro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphomaCorrado Tarella, Roberto Passera, Michele Magni, et al.
Scientific Reports|October 29, 2025
Conservation hints for Pinna nobilis from a century-old genetic time capsuleIlenia Azzena, Chiara Locci, Noemi Pascale, et al.
Leukemia|July 8, 2020
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myelomaMarco Rossi, Emanuela Altomare, Cirino Botta, et al.
BMC Genomics|January 11, 2014
Differential transcriptional profile of Corynebacterium pseudotuberculosis in response to abiotic stressesAnne Cybelle Pinto, Pablo Henrique Caracciolo Gomes de Sá, Rommel T J Ramos, et al.
Annals of Botany|October 24, 2024
Expanding the Triangle of U: Comparative analysis of the Hirschfeldia incana genome provides insights into chromosomal evolution, phylogenomics and high photosynthesis-related traitsNam V Hoang, Nora Walden, Ludovico Caracciolo, et al.
Leukemia|November 22, 2017
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cellsC Botta, M Cucè, M R Pitari, et al.
Blood|July 13, 2018
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92Eugenio Morelli, Lavinia Biamonte, Cinzia Federico, et al.
Cells|August 29, 2020
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced PneumonitisPierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, et al.
British Journal of Haematology|July 3, 2026
Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experienceAndrea Duminuco, Dario Leotta, Alessandro Allegra, et al.
Pageof 99